Daclatasvir Nitroso
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Daclatasvir is used along with another medication (sofosbuvir [Solvadi]) to treat a certain type of chronic hepatitis C (an ongoing viral infection that damages the liver). Daclatasvir is in a class of antiviral medications called hepatitis C virus (HCV) NS5A inhibitors.Daclatasvir Nitroso is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Daclatasvir Nitroso CAS NO:NA chemically represented as Methyl ((S)-1-((S)-2-(5-(4'-(2-((S)-1-((methoxycarbonyl)-L-valyl)pyrrolidin-2-yl)-1H-imidazol-5-yl)-[1,1'-biphenyl]-4-yl)-1-nitroso-1H-imidazol-2-yl)pyrrolidin-1-yl)-3-methyl-1-oxobutan-2-yl)carbamate. Synchemia is the leading manufacturing and exporter of Daclatasvir Nitroso . We supply Daclatasvir Nitroso with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0142099 |
| CAS No | NA |
| Mol.F. | C14H21N3O4 |
| Mol.Wt. | 295.34 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142100 |
| CAS No | NA |
| Mol.F. | C16H25N3O4 |
| Mol.Wt. | 323.39 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142101 |
| CAS No | NA |
| Mol.F. | C15H20N2O6 |
| Mol.Wt. | 324.33 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142102 |
| CAS No | NA |
| Mol.F. | C33H46N4O9 |
| Mol.Wt. | 642.75 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142103 |
| CAS No | NA |
| Mol.F. | C27H33N3O8 |
| Mol.Wt. | 527.57 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142104 |
| CAS No | NA |
| Mol.F. | C17H25N3O5 |
| Mol.Wt. | 351.40 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142105 |
| CAS No | NA |
| Mol.F. | C17H25N3O5 |
| Mol.Wt. | 351.40 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142106 |
| CAS No | NA |
| Mol.F. | C20H31N3O5 |
| Mol.Wt. | 393.48 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142107 |
| CAS No | NA |
| Mol.F. | C14H10Cl2N2O3 |
| Mol.Wt. | 325.15 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142108 |
| CAS No | NA |
| Mol.F. | C15H12Cl2N2O3 |
| Mol.Wt. | 339.17 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142109 |
| CAS No | NA |
| Mol.F. | C16H14Cl2N2O3 |
| Mol.Wt. | 353.20 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142110 |
| CAS No | NA |
| Mol.F. | C17H14Cl2N2O5 |
| Mol.Wt. | 397.21 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142111 |
| CAS No | NA |
| Mol.F. | C18H16Cl2NO5 |
| Mol.Wt. | 411.24 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142112 |
| CAS No | NA |
| Mol.F. | C23H18Cl2N2O5 |
| Mol.Wt. | 473.31g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142113 |
| CAS No | NA |
| Mol.F. | C18H14Cl2N2O7 |
| Mol.Wt. | 441.22 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142114 |
| CAS No | NA |
| Mol.F. | C20H16Cl2N2O9 |
| Mol.Wt. | 499.25 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |